BioTrinity – Panel: AIM v NASDAQ v European Listing – What’s best for you – London (24 April)
Approaching the 12th consecutive year, the goal of BioTrinity is to create an ideal network and partnering platform for the global life sciences industry under one roof, ultimately to help shape our healthcare future.
The theme for BioTrinity 2018 is ‘Next Generation Healthcare’ which will explore via a range of insightful keynote and panel discussions including ‘AI and Drug Discovery’, ‘An insight into Nanotechnology’, ‘Next Generation Chemistry’ and ‘The Evolution of the Life Science Investment Industry’.
BioTrinity offers unique access to investors, big pharma executives and innovative CEO’s of emerging R&D companies seeking to strike deals and grow their networks.
Anglonordic Life Science Conference – London (23 May)
Anglonordic is the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other.
Shares Investor Evening – Edinburgh (31 May) & Manchester (27 June)
The evening event provides an opportunity for Board Directors, from dynamic companies that are listed on the London Stock Exchange, to make a presentation and talk about their company business plans for 2018 direct to existing & potential investors.
During the event and afterwards over drinks, investors will have the chance to get to know the companies better by talking one on one with the company directors.
Proactive Investors One2One Investor Forum – London (12 July)
Proactive Investors One2One Forums have rapidly gained global recognition as the preferred format for hundreds of listed companies across the world’s leading stock exchanges seeking to present to an audience of astute high net worth investors, fund managers, private client brokers and analysts.
These events are tailor-made for private and professional investors who have exposure to equities, particularly growth stocks – or indeed anyone who is considering putting their money to work in dynamic sectors such as mining, oil and gas, technology and drug discovery.